您的位置:PharmaNews 研发动态 正文
内容搜索
热门内容
推荐内容
最新内容
反馈意见和建议

Covance Reports Second Quarter Revenue of $475M and EPS of $0.49; Updates Full-Year Financial Targets(13)
本文章共23214字,分15页,当前第13页,快速翻页:


        Unearned revenue                            (14,817)      11,111
        Income taxes payable                          3,994        15,694
        Other assets and liabilities, net            (9,454)    (13,033)
  Net cash provided by operating activities          81,372        58,636
                                                      ------        ------
  Cash flows from investing activities:
    Capital expenditures                            (67,461)    (70,911)
    Acquisition of business, net of cash acquired          -      (18,620)
    Proceeds from sale of business                        -          655
    Other, net                                            50            15
  Net cash used in investing activities              (67,411)    (88,861)
                                                    -------      -------
  Cash flows from financing activities:
    Stock issued under employee stock purchase and
    option plans                                      9,270        5,189
    Purchase of treasury stock                        (5,283)      (2,316)
    Net borrowings under revolving credit facility        -        8,000
    Payment of debt assumed upon acquisition of
    business                                              -        (5,431)
  Net cash provided by financing activities            3,987        5,442
                                                      -----        -----

 

 

点这里复制本页地址     发送给您QQ/MSN上的好友


相关文章

  Commonwealth Biotechnologies, Inc. Provi

Quintiles Announces New European Headqua

FDA Approves Drug for Chronic Drooling i

Abbott's Simcor ( niacin extended-releas

Abraxis BioScience and Specialised Thera

Shionogi Inc. Announces FDA Approval of

Researchers Solve Mystery of Uner Tan Sy

WaferGen Announces Purchase of SmartChip

Plant Compound Resveratrol Shown to Supp

New pathway to Parkinson's and Alzheimer

deCODE Shows how Genetic Risk of Kidney

相关评论

    
本文章所属分类:首页 研发动态